Q2 2025 CorVel Corp Earnings Call Transcript
Key Points
- CorVel Corp (CRVL) reported a 15% increase in revenue for the September quarter, reaching $224 million compared to $196 million in the same quarter of the previous year.
- Earnings per share increased by 17%, from $15 per share in the prior year to $35 per share in the current quarter.
- The company's network solutions offerings have seen significant growth due to increased investments, contributing to meaningful business expansions.
- CorVel Corp (CRVL) maintains a strong balance sheet with positive cash flow, providing financial flexibility for investments in technology and growth initiatives.
- The patient management segment continues to perform strongly, enhancing overall financial results.
- The trend towards vertical integration in healthcare has led to increased costs, with treatment costs rising by more than 10% due to higher utilization and specialty engagement.
- Inflationary pressures from operational expenses and increased demand for behavioral health services are contributing to rising healthcare costs.
- The integration of healthcare systems has resulted in increased visits and provider interactions, causing frustration among injured workers.
- Pharmacy pricing remains a contentious issue, with regulatory changes focusing on drug cost transparency and the complexity of pharmacy reimbursements.
- Despite the growth in network solutions, the initial costs for staffing and training before program launches have been significant.
Thank you for standing by. Welcome to the Corvel Corporation quarterly earnings release webcast. During the course of this webcast, Corvel Corporation may make projections or other forward-looking statements regarding future events or the future financial performances of the company.
Corvel wishes to caution you that these statements are only predictions and that actual events or results may differ. Materially. Corvel refers you to the documents that the company files from time to time with the Securities and Exchange Commission, specifically, the company's last form 10-K and 10-Q files for the most recent fiscal year and quarter.
These documents contain and identify important factors that could cause the actual results to differ materially from those contained in our projections or forward-looking statements.
I would now like to turn it over to Michael Combs, President and Chief Executive Officer.
Good morning. Thank you for joining us to review Corvel's September
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
